• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar

McCarter & English Logo

  • People
  • Services
  • Insights
  • Our Firm
    • Leadership Team
    • Social Justice
    • Diversity, Equity & Inclusion
    • Pro Bono
    • Client Service Values
    • Alumni
  • Join Us
    • Lawyers
    • Summer Associates
    • Patent Professionals
    • Professional Staff
    • Job Openings
  • Locations
    • Boston
    • Philadelphia
    • East Brunswick
    • Indianapolis
    • Stamford
    • Hartford
    • Trenton
    • Miami
    • Washington, DC
    • New York
    • Wilmington
    • Newark
  • Share

Share

Browse Alphabetically:

  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z
  • All
Bankruptcy, Restructuring & Litigation
Blockchain, Smart Contracts & Digital Currencies
Business Litigation
Cannabis
Coronavirus Resource Center
Corporate
Crisis Management
Cybersecurity & Data Privacy
Delaware Corporate, LLC & Partnership Law
Design, Fashion & Luxury
E-Discovery & Records Management
Energy & Utilities
Environment & Energy
Financial Institutions
Food & Beverage
Government Affairs
Government Contracts & Global Trade
Government Investigations & White Collar Defense
Healthcare
Hospitality
Immigration
Impact Investing
Insurance Recovery, Litigation & Counseling
Intellectual Property
Labor & Employment
Life Sciences
Manufacturing
Products Liability, Mass Torts & Consumer Class Actions
Public Finance
Real Estate
Renewable Energy
Sports & Entertainment
Tax & Employee Benefits
Technology Transactions
Transportation, Logistics & Supply Chain Management
Trusts, Estates & Private Clients
Venture Capital & Emerging Growth Companies
  • Broadcasts
  • Events
  • News
  • Publications
  • View All Insights
Search By:
Jill Ann Mello, PhD
Alternate image for Jill Ann Mello, PhD

Jill Ann Mello, PhD

Partner

617.449.6563
Boston
jmello@mccarter.com

An ardent commercial strategist, Jill optimizes her foundation in biochemistry in pursuit of her clients’ objectives.

Dr. Jill Ann Mello has more than 18 years of experience as a patent professional. Her practice focuses on the life sciences, and includes particular experience in the technology areas of biotechnology, molecular biology, immunology, microbiology, molecular diagnostics, cell-based therapeutics, nucleic acid therapeutics, protein therapeutics including antibodies, small molecule therapeutics, drug formulations, drug discovery platform technologies, and bioinformatics.

Jill has extensive experience assisting clients in the strategic development and management of complex patent portfolios worldwide that are aligned with her clients’ business objectives. She assists clients with patentability analysis, validity, infringement, and freedom-to-operate opinions; with IP due diligence for acquisitions, licensing, and financings, including initial public offerings; as well as with the negotiation of collaboration and license agreements. Jill has experience with involvement in opposition proceedings before the European Patent Office. She represents a wide array of clients including early stage companies, small and mid-size biotechnology companies, pharmaceutical corporations, academic institutions, and venture-capital firms.

Prior to joining the firm, Jill earned her PhD in Biochemistry from the Massachusetts Institute of Technology. Her doctoral thesis focused on elucidating the therapeutic mechanisms of the anticancer drug cisplatin. Following her PhD, Jill carried out postdoctoral research on chromatin dynamics at the Curie Institute in Paris, France, for which she was the recipient of a Chateaubriand fellowship from the French government. Her work has been presented at international scientific meetings, and has been published in leading peer reviewed journals.

Representative Matters

ArcherDX—Patent litigation

Represented biotech company ArcherDX in a jury trial in Delaware federal court. Jury found that European genetic testing company Qiagen willfully infringed a pair of patents owned by ArcherDX and Massachusetts General Hospital, awarding royalties and lost profits totaling about $4.7 million.

Highlights

Recognitions

Recognition image 10997
IAM Patent 1000, 2020–2022
Ranking Disclaimers: No aspect of this advertisement has been approved by the Supreme Court of New Jersey. For IAM Patent 1000 methodology, see https://www.iam-media.com/directories/patent1000/info/methodology.

sidebar

pdfemail

Services

Intellectual Property
Patents
Life Sciences

Education

Suffolk University Law School JD, 2007
Massachusetts Institute of Technology PhD Biochemistry, 1997
Columbia University MA Chemistry, 1990
Trinity College BS, Valedictorian, 1988

Bar Admissions

Massachusetts
U.S. Patent & Trademark Office

Memberships & Certifications

Boston Patent Law Association

Boston Bar Association

Women's Bar Association

intellectual property
News|Recognition
IAM Patent 1000 Recognizes McCarter for Excellence in Patent Law
6.29.2022
Media item displaying Jury Awards $4.7 million in Mass. General Genetic Test Patent Trial
News
Jury Awards $4.7 million in Mass. General Genetic Test Patent Trial
Law360
8.30.2021
Media item displaying IAM Patent 1000 Recognizes McCarter’s Leading Patent Law Practice
News|Recognition
IAM Patent 1000 Recognizes McCarter’s Leading Patent Law Practice
IAM Patent 1000
7.21.2021
Insights Awards Top Stars
News|Recognition
IAM Patent 1000 Recognizes McCarter for Transactional, Litigation, and Prosecution Practices in Patent Professionals Rankings for 2020
6.23.2020
Insights News Headline Stack
News|Press
Chondrial Therapeutics and Zafgen Announce Definitive Merger Agreement
12.18.2019
McCarter & English, LLP
Copyright © 2023 McCarter & English, LLP. All Rights Reserved.
  • Login
  • Attorney Advertising
  • Privacy
  • Awards Methodology
  • Contact
  • Subscribe
  • Sitemap

The McCarter & English, LLP website is for informational purposes only. We do not provide legal advice on this website. We can provide legal advice only to our clients in specific inquiries that they address to us. If you are interested in becoming a client, please contact us, but do not send any information about your specific legal question. We cannot serve as your lawyers until we establish an attorney-client relationship, which can occur only after we follow procedures within our firm and after we agree to the terms of the representation.

Accept Cancel